| Typicality: | 0.330 |
| Saliency: | 0.189 |
| up to age | 4 | other |
| currently | 2 | temporal |
| vaccine → be approved for → young women | 5 |
| vaccine → be approved for → woman | 4 |
| vaccine → be approved for → female | 3 |
| negative | neutral | positive |
| 0.014 | 0.602 | 0.385 |
| Raw frequency | 12 |
| Normalized frequency | 0.189 |
| Modifier score | 0.500 |
| Perplexity | 164.951 |